Erythema nodosum and the risk of tuberculosis in a high incidence setting

Int J Circumpolar Health. 2016 Oct 25:75:32666. doi: 10.3402/ijch.v75.32666. eCollection 2016.

Abstract

Objective: This study estimates the erythema nodosum (EN) incidence in a tuberculosis (TB) endemic setting and evaluates the likelihood of a subsequent TB diagnosis among individuals with Mycobacterium tuberculosis infection (MTI) with or without EN.

Design: We estimated EN incidence rates (IRs) in East Greenland in 2010-2011 and conducted a cohort study following all individuals who tested positive for MTI from 1 January 2010 until 31 December 2012. A personal identifier allowed individual follow-up in the mandatory TB register. MTI was defined by a positive interferon-gamma release assay. TB incidence rate ratios (IRRs) among participants with or without EN were estimated with the Cox proportional hazard model.

Results: We identified 38 EN cases corresponding to an IR of 500/100,000 inhabitants/year. All cases were among individuals with MTI. The EN IR was 11.79 (95% CI 5.73-24.27) times higher for BCG-unvaccinated compared with BCG-vaccinated individuals. The TB IRR was 25 (95% CI 11-60) within 1 month of EN compared to individuals without EN.

Conclusion: This study documents a high EN incidence in a TB endemic region. EN occurred only in individuals with MTI, and predominantly among BCG-unvaccinated individuals. EN was significantly associated with a TB diagnosis within 1 month of diagnosis.

Keywords: Erythema Nodosum; Greenland; Tuberculosis; interferon gamma release assay; mycobacterium tuberculosis.

Publication types

  • Review

MeSH terms

  • Adult
  • BCG Vaccine
  • Causality
  • Cohort Studies
  • Erythema Nodosum / diagnosis*
  • Erythema Nodosum / epidemiology
  • Female
  • Greenland
  • Humans
  • Incidence
  • Interferon-gamma Release Tests
  • Male
  • Mycobacterium tuberculosis / isolation & purification*
  • Risk Factors
  • Tuberculosis / diagnosis*
  • Tuberculosis / epidemiology
  • Tuberculosis, Pulmonary / diagnosis
  • Young Adult

Substances

  • BCG Vaccine